Researchers Database
ASO YOSHIMASA
Affiliation： Department of Endocrinology and Metabolism Position： Professor | |||
Last Updated :2026/04/21
Research achievements
Published Papers
- 133, 10-12, Nov. 2017
- 130, 237-243, Aug. 2017
- 8(4), 821-827, Aug. 2017
- 261, 44-51, Jun. 2017
- 18(8), 743-751, Jun. 2017
- 8(2), 445-449, Apr. 2017
- 79, 9-16, Feb. 2017
- 56, 17-21, Jan. 2017
- 8, 45, Jul. 2016
- 15, 76-85, May 2016
- 7(25), 25-33, Mar. 2016
- 50(3), 659-664, Dec. 2015
- 110(3), 250-256, Dec. 2015
- 49(2), 91-96, Feb. 2015
- 165, 336-345, Feb. 2015
- 5(2), 403-413, Dec. 2014
- 41(3), 211-220, Oct. 2014
- 162(5), 309-316, Nov. 2013
- 30(10), 897-906, Oct. 2013
- 2013, bcr2012008290, Jun. 2013
- 120(2), 121-128, Aug. 2012
- 159, 25-31, Jan. 2012
- 159, 15-24, Jan. 2012
- 29, 80-87, Jan. 2012
- 32(3), 701-706, Mar. 2012
- CD-1db/db mice: A novel type 2 diabetic mouse model with progressive kidney fibrosis., Mizunuma Yuiko;Kanasaki Keizo;Nitta Kyoko;Nakamura Yuka;Ishigaki Yasuhito;Takagaki Yuta;Kitada Munehiro;Li Shaolan;Liu Haijie;Li Jinpeng;Usui Isao;Aso Yoshimasa;Koya Daisuke, Journal of diabetes investigation, 11(6), 1470-1481, Nov. 2020
- Teneligliptin, a DPP-4 Inhibitor, Decreases Plasma Levels of Inflammatory Chemokines During a Standard Meal Test in Patients With Type 2 Diabetes., Aso Yoshimasa;Kase Masato;Sagara Masaaki;Sakurai Shintaro;Iijima Toshie;Tomaru Takuya;Jojima Teruo;Usui Isao, The American journal of the medical sciences, 360(3), 261-267, 2020
- Empagliflozin decreases the plasma concentration of plasminogen activator inhibitor-1 (PAI-1) in patients with type 2 diabetes: Association with improvement of fibrinolysis., Sakurai Shintaro;Jojima Teruo;Iijima Toshie;Tomaru Takuya;Usui Isao;Aso Yoshimasa, Journal of diabetes and its complications, 34(11), 107703, 2020
- No Negative Impact of a National State of Emergency by COVID-19 Outbreak on Hemoglobin A1c Levels in Patients With Type 2 Diabetes Living in Semi-Rural Japan., Aso Yoshimasa;Iijima Toshie;Tomaru Takuya;Jojima Teruo;Usui Isao, The American journal of the medical sciences, 362(1), 104-105, 31 Mar. 2021
- Serum high-molecular-weight adiponectin and response to dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease., Aso Yoshimasa;Sagara Masaaki;Niitani Takafumi;Kato Kanako;Iijima Toshie;Tomaru Takuya;Jojima Teruo;Usui Isao, Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 69(7), 1324-1329, 21 May 2021
- Acute effect of add-on therapy with tofogliflozin, a sodium glucose co-transporter 2 inhibitor, on 24-hours glucose profile and glycaemic variability evaluated by continuous glucose monitoring in patients with type 2 diabetes receiving dipeptidyl peptidase-4 inhibitors., Iijima Toshie;Hosonuma Soichiro;Kurai Hidetaka;Kajitani Hayato;Sakurai Shintaro;Tomaru Takuya;Jojima Teruo;Usui Isao;Aso Yoshimasa, International journal of clinical practice, 75(11), e14732, 19 Aug. 2011
- Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with significant fibrosis., Sagara Masaaki;Iijima Toshie;Kase Masato;Kato Kanako;Sakurai Shintaro;Tomaru Takuya;Jojima Teruo;Usui Isao;Aso Yoshimasa, Journal of diabetes and its complications, 35(5), 107885, 06 Feb. 2021
- Empagliflozin increases plasma levels of campesterol, a marker of cholesterol absorption, in patients with type 2 diabetes: Association with a slight increase in high-density lipoprotein cholesterol., Jojima Teruo;Sakurai Shintaro;Wakamatsu Sho;Iijima Toshie;Saito Masahiro;Tomaru Takuya;Kogai Takahiko;Usui Isao;Aso Yoshimasa, International journal of cardiology, 331, 243-248, 05 Feb. 2021
- High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetes., Aso Yoshimasa;Iijima Toshie;Jojima Teruo;Saito Masahiro;Tanuma Dai;Kase Masato;Sakurai Shintaro;Tomaru Takuya;Usui Isao, Postgraduate medicine, 136(3), 318-324, 29 Apr. 2024
- Empagliflozin increases plasma levels of citrulline, histidine, and α-aminobutyric acid in patients with type 2 diabetes: effects of a sodium-glucose co-transporter 2 inhibitor on the plasma amino acid profile., Jojima Teruo;Sakurai Shintaro;Kishi Haruka;Kato Kananko;Iijima Toshie;Tomaru Takuya;Usui Isao;Aso Yoshimasa, Expert opinion on pharmacotherapy, 25(7), 937-944, 04 Jun. 2024
- Impact of inpatient management of hyperglycemia on peripheral T cell markers in patients with type 2 diabetes., Kunii Tomohisa;Usui Isao;Jojima Teruo;Shimizu Masanori;Kase Masato;Sakurai Shintaro;Tomaru Takuya;Iijima Toshie;Aso Yoshimasa, Diabetology international, 15(3), 414-420, 26 Feb. 2024
- Patients with diabetes and obesity exhibit characteristics in eating and coping behaviors and personality traits., Saito Masahiro;Usui Isao;Sugawara Norio;Jojima Teruo;Sakurai Shintaro;Kishi Haruka;Sagara Masaaki;Tomaru Takuya;Iijima Toshie;Shimoda Kazutaka;Yasui-Furukori Norio;Aso Yoshimasa, Diabetology international, 15(3), 528-534, 16 Apr. 2024
- Acute Effect of Imeglimin Add-on Therapy on 24-h Glucose Profile and Glycemic Variability in Patients with Type 2 Diabetes Receiving Metformin., Shinohara Yasutake;Jojima Teruo;Kamiga Yusuke;Sakurai Shintaro;Iijima Toshie;Tomaru Takuya;Akutsu Ikuo;Inoue Teruo;Usui Isao;Aso Yoshimasa, Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 33(6), 569-577, 12 Aug. 2024
Original paper
- Diabetes with GLP-1R polymorphism (rs3765467) accompanied by myotonic dystrophy: A case of myotonic dystrophy with p.R131Q polymorphism at the glucagon-like peptide-1 receptor (rs3765467) resulting in marked effects of its agonist, dulaglutide., Kato Kanako;Jojima Teruo;Kogai Takahiko;Tanuma Dai;Niitani Takafumi;Sakurai Shintaro;Iijima Toshie;Tomaru Takuya;Usui Isao;Aso Yoshimasa, The American journal of the medical sciences, 369(1), 126-130, 08 Jul. 2024
Review paper
- Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case report., Jojima Teruo;Kogai Takahiko;Iijima Toshie;Kato Kanako;Sagara Masaaki;Kezuka Atsumi;Kase Masato;Sakurai Shintaro;Akimoto Kazumi;Sakumoto Junko;Namatame Takashi;Ueki Keisuke;Hishinuma Akira;Kamai Takao;Usui Isao;Aso Yoshimasa, European journal of endocrinology, 183(6), K7-K12, Dec. 2020
- Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor showing unfavorable outcomes despite immediate discontinuation of medication., Shinohara Yasutake;Iijima Toshie;Sakurai Shintaro;Jojima Teruo;Ohira Eriko;Hayashi Shujiro;Usui Isao;Igawa Ken;Aso Yoshimasa, Clinical case reports, 8(10), 2007-2012, Oct. 2020
- A case of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome with a novel frameshift variant in GATA3, p.W10Cfs40, lacks kidney malformation., Kishi Haruka;Jojima Teruo;Kogai Takahiko;Iijima Toshie;Ohira Eriko;Tanuma Dai;Konno Sachiyo;Kato Kanako;Kezuka Atsumi;Akimoto Kazumi;Sakumoto Junko;Hishinuma Akira;Tomaru Takuya;Makita Noriko;Usui Isao;Aso Yoshimasa, Clinical case reports, 8(12), 2619-2624, Dec. 2020
- Symptomatic hypocalcemia after treatment for hyperthyroidism in a woman with chromosome 22q11.2 deletion syndrome complicated by Graves' disease: longitudinal changes in the number of subsets of CD4 and CD8 lymphocytes after thyroidectomy., Iijima Toshie;Jojima Teruo;Hosonuma Soichiro;Ohhira Eriko;Tomaru Takuya;Kogai Takahiko;Usui Isao;Aso Yoshimasa, Endocrine journal, 68(10), 1187-1195, 28 Oct. 2021
- Thyroid storm after coronavirus disease 2019 mRNA vaccination in a patient with a history of Graves' disease after coronavirus disease 2019 infection., Saito Masahiro;Iijima Toshie;Kurai Hidetaka;Aso Yosimasa, BMJ case reports, 17(6), 04 Jun. 2024
Case report